Corcept Therapeutics Incorporated (Nasdaq: CORT) is a commercial-stage biopharmaceutical company that discovers, develops and commercializes drugs modulating cortisol activity at the glucocorticoid receptor to treat severe metabolic, oncolo…
HQ: Redwood City, CA, United States of Americawww.corcept.com
USD72.94-1.04%vs prev. close
Performance
1W
+2.90%
1M
-37.43%
3M
-33.30%
1Y
-5.97%
YTD
+111.81%
Valuation
P/E
55.3
EPS TTM
1.32
Dividend yield
—
Size and risk
Market cap
$8.0B
Beta
0.56
Price history
CORT price
USD
Total returnEventsVs index
Loading…
Next earnings
Report date
EPS estimate
Revenue estimate
Peer comparison
Corcept Therapeutics
CORT
Biotechnology
Mkt cap (USD bn)
8.0
P/E
55.3
Div yld
—
1W
+2.9%
1M
-37.4%
3M
-33.3%
6M
+26.4%
1Y
-6.0%
YTD
+111.8%
Company
Ticker
Industry
Mkt cap (USD bn)
P/E
Div yld
1W
1M
3M
6M
1Y
YTD
Corcept Therapeutics
CORT
Biotechnology
8.0
55.3
—
+2.9%
-37.4%
-33.3%
+26.4%
-6.0%
+111.8%
Subscribe to Equity Analytics to compare CORT with its closest peers
Sector-matched peer set with side-by-side valuation, dividend and performance over every window.